Citations

Showing 10 of 108083 citations.

Opioid Neurotoxicity Treated with Intrathecal Drug Delivery System Implant
Wu, Kelly L. , Strand, Jacob J. , Moeschler, Susan M. , Pittelkow, Thomas P.

Mayo Clinic

Journal of Palliative Medicine | November 7, 2017 | Volume: 21 | Issue: 2 | Pages: 126-126

10.1089/jpm.2017.0517 | PMID 29112460 Get It

Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia
Beam, Elena , Germer, Jeffrey J., Lahr, Brian D. , Yao, Joseph D. , Binnicker, Matthew J. , Lahr, Brian, Yao, Joseph D C, Limper, Andrew Harold, Beam, Elena , Limper, Andrew H. , Razonable, Raymund R.

Mayo Clinic

Clinical Transplantation | November 7, 2017 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/ctr.13149 | PMID 29112278 Get It

AbstractCytomegalovirus (CMV) pneumonia causes major morbidity and mortality. Its diagnosis requires demonstration of viral cytopathic changes in tissue, entailing risks of lung biopsy. This study aimed to determine CMV viral load (VL) thresholds in bronchoalveolar lavage fluid (BALF) for diagnosis of CMV pneumonia in immunocompromised patients. CMV VL in BALF was studied in 17 patients (83% transplant recipients) and 21 control subjects with and without CMV pneumonia, respectively, using an FDA‐approved PCR assay (Cobas® AmpliPrep/Cobas TaqMan® CMV Test, Roche Molecular Systems, Inc.) calibrated to the WHO International Standard for CMV DNA (NIBSC: 09/162). Receiver operating characteristic curve analysis produced a BALF CMV VL threshold of 34 800, IU/mL with 91.7% sensitivity and 100.0% specificity for diagnosis of possible, probable, and proven CMV pneumonia in transplant patients, while a threshold of 656 000 IU/mL yielded 100% sensitivity and specificity among biopsy‐proven cases. For all immunocompromised patients, a VL threshold of 274 IU/mL was selected. VL thresholds also were normalized to BALF cell count yielding a threshold of 0.32 IU/106 cells with 91.7% sensitivity and 90.5% specificity for possible, probable, and proven CMV pneumonia in transplant recipients. Monitoring CMV VL in BALF may be a less invasive method for diagnosing CMV pneumonia in immunocompromised patients.
Muscle hernias of the leg: A case report and comprehensive review of the literature
Nguyen, Jesse T., Nguyen, Jenny Lee , Wheatley, Michael J., Nguyen, Tuan Anh

Mayo Clinic

Canadian Journal of Plastic Surgery | November 7, 2017 | Volume: 21 | Issue: 4 | Pages: 243-247

10.1177/229255031302100408 Get It

A case involving a retired, elderly male war veteran with a symptomatic peroneus brevis muscle hernia causing superficial peroneal nerve compression with chosen surgical management is presented. Symptomatic muscle hernias of the extremities occur most commonly in the leg and are a rare cause of chronic leg pain. Historically, treating military surgeons pioneered the early documentation of leg hernias observed in active military recruits. A focal fascial defect can cause a muscle to herniate, forming a variable palpable subcutaneous mass, and causing pain and potentially neuropathic symptoms with nerve involvement. While the true incidence is not known, the etiology has been classified as secondary to a congenital (or constitutional) fascial weakness, or acquired fascial defect, usually secondary to direct or indirect trauma. The highest occurrence is believed to be in young, physically active males. Involvement of the tibialis anterior is most common, although other muscles have been reported. Dynamic ultrasonography or magnetic resonance imaging is often used to confirm diagnosis and guide treatment. Most symptomatic cases respond successfully to conservative treatment, with surgery reserved for refractory cases. A variety of surgical techniques have been described, ranging from fasciotomy to anatomical repair of the fascial defect, with no consensus on optimal treatment. Clinicians must remember to consider muscle hernias in their repertoire of differential diagnoses for chronic leg pain or neuropathy. A comprehensive review of muscle hernias of the leg is presented to highlight their history, occurrence, presentation, diagnosis and treatment.
Women's Health Endocrine Update
Kapoor, Ekta , Hines, Stephanie L., Stuenkel, Cynthia A. , Faubion, Stephanie, Hines, Stephanie, Faubion, Stephanie S.

Mayo Clinic

Journal of Women's Health | November 7, 2017 | Volume: 26 | Issue: 12 | Pages: 1365-1368

10.1089/jwh.2017.6434 | PMID 29111858 Get It

Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway
Qin, Chuan , Fan, Wen-Hui, Shang, Ke , Murugan, Madhuvika , Wu, Long‐Jun , Wang, Wei , Tian, Dai‐Shi , Wu, Long-Jun , Tian, Dai-Shi , Liu, Qian

Mayo Clinic

Stroke | November 7, 2017 | Volume: 48 | Issue: 12 | Pages: 3336-3346

10.1161/strokeaha.117.018505 | PMID 29114096 Get It

Background and Purpose— White matter (WM) ischemic injury, a major neuropathological feature of cerebral small vessel diseases, is an important cause of vascular cognitive impairment in later life. The pathogenesis of demyelination after WM ischemic damage are often accompanied by microglial activation. Fingolimod (FTY720) was approved for the treatment of multiple sclerosis for its immunosuppression property. In this study, we evaluated the neuroprotective potential of FTY720 in a WM ischemia model. Methods— Chronic WM ischemic injury model was induced by bilateral carotid artery stenosis. Cognitive function, WM integrity, microglial activation, and potential pathway involved in microglial polarization were assessed after bilateral carotid artery stenosis. Results— Disruption of WM integrity was characterized by demyelination in the corpus callosum and disorganization of Ranvier nodes using Luxol fast blue staining, immunofluorescence staining, and electron microscopy. In addition, radial maze test demonstrated that working memory performance was decreased at 1-month post–bilateral carotid artery stenosis–induced injury. Interestingly, FTY720 could reduce cognitive decline and ameliorate the disruption of WM integrity. Mechanistically, cerebral hypoperfusion induced microglial activation, production of associated proinflammatory cytokines, and priming of microglial polarization toward the M1 phenotype, whereas FTY720 attenuated microglia-mediated neuroinflammation after WM ischemia and promoted oligodendrocytogenesis by shifting microglia toward M2 polarization. FTY720’s effect on microglial M2 polarization was largely suppressed by selective signal transducer and activator of transcription 3 (STAT3) blockade in vitro, revealing that FTY720-enabled shift of microglia from M1 to M2 polarization state was possibly mediated by STAT3 signaling. Conclusions— Our study suggested that FTY720 might be a potential therapeutic drug targeting brain inflammation by skewing microglia toward M2 polarization after chronic cerebral hypoperfusion.
Mitochondrial targeted HSP90 inhibitor Gamitrinib-TPP (G-TPP) induces PINK1/Parkin-dependent mitophagy
Fiesel, Fabienne C. , James, Elle D., Hudec, Roman, Springer, Wolfdieter , Fiesel, Fabienne C , Springer, Wolfdieter

Mayo Clinic

Oncotarget | November 6, 2017 | Volume: 8 | Issue: 63 | Pages: 106233-106248

10.18632/oncotarget.22287 | PMID 29290944 Get It

Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research
Fowler, Vance G. , Evans, Scott R , Huskins, W. Charles , Fowler, Vance G. , Evans, Scott

Mayo Clinic

Clinical Infectious Diseases | November 6, 2017 | Volume: 66 | Issue: 7 | Pages: 1140-1146

10.1093/cid/cix907 | PMID 29121202 Get It

Letter by Maltais et al Regarding Article, “Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure”
Maltais, Simon, Tchantchaleishvili, Vakhtang , Stulak, John M., Tchantchaleishvili, Vakhtang

Mayo Clinic

Circulation | November 6, 2017 | Volume: 136 | Issue: 19 | Pages: 1870-1871

10.1161/circulationaha.117.028984 | PMID 29109201 Get It

Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans
Sharma, Anu , Varghese, Ron T. , Man, Chiara Dalla , Rizza, Robert A., Bailey, Kent R. , Dalla Man, Chiara , Shah, Mithun V , Cobelli, Claudio , Vella, Adrian

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | November 6, 2017 | Volume: 103 | Issue: 1 | Pages: 314-319

10.1210/jc.2017-01197 | PMID 29126197 Get It

Abstract Context Abnormal glucagon concentrations contribute to hyperglycemia, but the mechanisms of α-cell dysfunction in prediabetes are unclear. Objective We sought to determine the relative contributions of insulin secretion and action to α-cell dysfunction in nondiabetic participants across the spectrum of glucose tolerance. Design This was a cross-sectional study. A subset of participants (n = 120) was studied in the presence and absence of free fatty acid (FFA) elevation, achieved by infusion of Intralipid (Baxter Healthcare, Deerfield, IL) plus heparin, to cause insulin resistance. Setting An inpatient clinical research unit at an academic medical center. Participants A total of 310 nondiabetic persons participated in this study. Interventions Participants underwent a seven-sample oral glucose tolerance test. Subsequently, 120 participants were studied on two occasions. On one day, infusion of Intralipid plus heparin raised FFA. On the other day, participants received glycerol as a control. Main Outcome Measure(s) We examined the relationship of glucagon concentration with indices of insulin action after adjusting for the effects of age, sex, and weight. Subsequently, we sought to determine whether an acute decrease in insulin action, produced by FFA elevation, altered glucagon concentrations in nondiabetic participants. Results Fasting glucagon concentrations correlated positively with fasting insulin and C-peptide concentrations and inversely with insulin action. Fasting glucagon was not associated with any index of β-cell function in response to an oral challenge. As expected, FFA elevation decreased insulin action and also raised glucagon concentrations. Conclusions In nondiabetic participants, glucagon secretion was altered by changes in insulin action.
Medial Closing‐Wedge Distal Femoral Osteotomy with Medial Patellofemoral Ligament Imbrication for Genu Valgum with Lateral Patellar Instability
Sabbag, Orlando D., Wu, Isabella T. , Krych, Aaron J. , Woodmass, Jarret M, Krych, Aaron J , Woodmass, Jarret Murray , Stuart, Michael J.

Mayo Clinic

Arthroscopy Techniques | November 6, 2017 | Volume: 6 | Issue: 6 | Pages: No page available

10.1016/j.eats.2017.08.012 | PMID 29349001 Get It

Abstract A varus‐producing distal femoral osteotomy (DFO) is an effective technique for the treatment of lateral patellar instability (LPI) in patients with concomitant moderate to severe valgus malalignment. Patellar maltracking and subluxation are corrected via neutralization of some of the laterally directed forces on the patella due to the valgus deformity. This can be accomplished with a distal femoral lateral opening‐wedge or medial closing‐wedge osteotomy and medial soft tissue stabilization. A medial closing‐wedge osteotomy offers the advantages of immediate weight bearing and a single incision in cases requiring patellofemoral soft tissue stabilization. In this article, we describe our preferred operative technique for a medial closing‐wedge DFO using a femoral locking plate and medial patellofemoral ligament imbrication for the correction of LPI. Technique Video video See video under supplementary data.